Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
Individualized responsive dosing pharmanutrient systems, compositions, methods of dosing, and processes of producing the same, which allow a consumer to generate individualistic biological responses/effects. More specifically, a pharmanutrient system for generating individualized biological conditions/responses which utilizes ultra-low dosage amounts of vitamins, minerals, amino acids, co-enzymes, organics substrates, inorganic or synthetic substrates, biological components, and/or other nutrients incorporated or provided with a pharmacologically active ingredient in a bio-active delivery system which preferably avoids first pass metabolism, such that an individual may take multiple doses of the same or different pharmanutrient based on varying desired biological response within each dosing period.
1. A pharmanutrient dosing method comprising selecting from two or more different formulations provided as oral strips, sublingual liquids or sprays which substantially avoid first pass metabolism, wherein each pharmanutrient formulation comprises five or more of the following in an amount equal to about 5 drops in a liquid:
about 2.77×10 −7 g magnesium;
about 4.16×10 −7 g sodium;
about 1.09×10 −6 g potassium;
about 2.93×10 −7 g calcium;
about 2.31×10 −6 g ascorbic acid;
about 2.19×10 −7 g caffeine;
about 4.62×10 −8 g niacin;
about 1.73×10 −9 g chromium;
about 1.44×10 −7 g coenzyme Q-10;
about 1.16×10 −6 g L-glutamine
about 4.76×10 −8 g vitamin A;
about 8.33×10 −10 g vitamin B1;
about 6.29×10 −1 ° q vitamin B2;
about 8.02×10 −9 g vitamin B3;
about 8.02×10 −9 g vitamin B6;
about 2.41×10 −12 g vitamin B12;
about 2.41×10 −8 g vitamin C;
about 3.81×10 −9 g vitamin D3;
about 2.78×10 −10 g vitamin E;
about 7.22×10 −11 g vitamin H;
about 7.7×10 −11 g folic acid;
about 3.53×10 −10 g copper;
about 3.06×10 −9 g iron; or
about 2.58×10 −9 g zinc,
and further wherein at least one of the two or more different formulations comprises:
at least one other pharmacologically active ingredient selected from the group consisting of analgesic agents, antihistamines, antacids, antiflatulants, laxatives, antidiarrheals, and stimulants; and
administering the selected formulation to a recipient which substantially avoids first pass metabolism.
2. The method of claim 1 , wherein the vitamins, minerals, amino acids, or co-enzyme Q-10 include at least five or more of the members of the group consisting of: vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B12, vitamin C, vitamin D3, vitamin E, vitamin H, folic acid, copper, iron, potassium iodide, calcium carbonate, and zinc.